racemethionine has been researched along with Benign Neoplasms in 16 studies
Racemethionine: A preparation of METHIONINE that includes a mixture of D-methionine and L-methionine isomers.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Normal and cancer stem cells share similar characteristics in relation to their stemness properties." | 2.82 | Stemness of Normal and Cancer Cells: The Influence of Methionine Needs and SIRT1/PGC-1α/PPAR-α Players. ( Chéry, C; Guéant, JL; Namour, F; Oussalah, A; Siblini, Y, 2022) |
| "Lung, prostate, and esophageal cancer persister cells remaining after treatments exhibited several hallmarks indicative of pyroptosis resistance." | 1.91 | Elevated Methionine Flux Drives Pyroptosis Evasion in Persister Cancer Cells. ( Berglund, A; Brown, J; El-Kenawi, A; Estrella, V; Gatenby, R; Johnson, J; Liu, M; Putney, RM; Yoder, SJ; Zhang, Y, 2023) |
| "Various cancer cells overexpress L-type amino acid transporter 1 (LAT1) to take up a large number of neutral amino acids such as phenylalanine and methionine, and LAT1 transporter should be a promising target for cancer diagnosis and therapy." | 1.91 | Polymeric ligands comprising sulfur-containing amino acids for targeting tumor-associated amino acid transporters. ( Guo, H; Honda, Y; Kanamori, K; Matsui, M; Nishiyama, N; Nomoto, T; Takemoto, H; Voon, YM; Xu, W; Yamada, N, 2023) |
| "Methionine metabolism has a significant impact on T cells' survival and activation even in comparison to arginine, a well-documented amino acid in metabolic therapy." | 1.91 | Labeling Assembly of Hydrophilic Methionine into Nanoparticle for Mild-Heat Mediated Immunometabolic Therapy. ( Chong, G; Dong, H; Gu, J; He, R; Li, Y; Liu, B; Liu, Y; Yang, Y; Yin, W; Zang, J; Zhang, T; Zhao, Y; Zheng, X, 2023) |
| "A new therapeutic approach against cancer is developed by the firm Erytech." | 1.91 | Pharmacokinetic/pharmacodynamic model of a methionine starvation based anti-cancer drug. ( Bessonov, N; Eymard, N; Gueyffier, F; Kurbatova, P; Nony, P; Volpert, V, 2023) |
| "The genetic ablation of SLC43A2 in cancer cells restores methionine metabolism in CD4 T cells, increasing the intracellular levels of S-adenosylmethionine and yielding H3K79me2." | 1.91 | Methionine consumption by cancer cells drives a progressive upregulation of PD-1 expression in CD4 T cells. ( Ahn, JH; Chang, JH; Gu, Y; Han, Y; Jeong, MS; Kang, B; Kil, YS; Kim, JO; Ko, HJ; Mishra, S; Nam, JW; Ouh, YT; Pandit, M; Pokhrel, RH, 2023) |
| "The engineered microbes target solid tumors and induce a sharp regression in several very divergent animal models of human carcinomas, cause a significant decrease in tumor cell invasion, and essentially eliminate the growth and metastasis of these tumors." | 1.91 | Targeted deprivation of methionine with engineered Salmonella leads to oncolysis and suppression of metastasis in broad types of animal tumor models. ( Lai, Y; Li, F; Liang, Z; Lin, Y; Lu, M; Mo, X; Mu, Y; Qu, J; Shao, Z; Shen, H; Wang, X; Zhao, AZ; Zhao, Z; Zhou, S, 2023) |
| "Corticotroph tumors were identified in all 5 patients, even though one of them had negative MET uptake." | 1.91 | Clinical decision-making based on 11C-methionine PET in recurrent Cushing's disease with equivocal MRI findings. ( Hotta, M; Inoshita, N; Ishida, A; Kaneko, K; Minamimoto, R; Takano, K; Yamada, S, 2023) |
| "However, how MR impacts cancer progression in the context of the intact immune system is unknown." | 1.91 | Methionine restriction-induced sulfur deficiency impairs antitumour immunity partially through gut microbiota. ( Anantharaman, K; Andrea Azcarate-Peril, M; Arbeev, KG; Garcia-Peterson, LM; Hsiao, YC; Ji, M; Li, JL; Li, X; Liu, J; Lu, K; Martin, C; Popov, V; Randall, TA; Shats, I; Ukraintseva, S; Wan, Y; Wu, X; Xu, Q; Xu, X; Yashin, AI, 2023) |
| "Among breast cancer survivors, decreased methionine intake after breast cancer diagnosis was associated with lower risk of all-cause and breast cancer mortality." | 1.72 | Changes in Dietary Intake of Methionine, Folate/Folic Acid and Vitamin B12 and Survival in Postmenopausal Women with Breast Cancer: A Prospective Cohort Study. ( Bao, W; Cheng, TD; Fowke, JH; Johnson, KC; Liang, X; Liu, B; Mozhui, K; Saquib, N; Sen, S; Shadyab, AH; Snetselaar, LG; Sun, Y; Wallace, RB, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 16 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, T | 1 |
| Tan, YT | 1 |
| Chen, YX | 1 |
| Zheng, XJ | 1 |
| Wang, W | 2 |
| Liao, K | 1 |
| Mo, HY | 1 |
| Lin, J | 1 |
| Yang, W | 1 |
| Piao, HL | 1 |
| Xu, RH | 1 |
| Ju, HQ | 1 |
| Siblini, Y | 3 |
| Namour, F | 3 |
| Oussalah, A | 3 |
| Guéant, JL | 3 |
| Chéry, C | 3 |
| Sun, Y | 3 |
| Fowke, JH | 3 |
| Liang, X | 3 |
| Mozhui, K | 3 |
| Sen, S | 3 |
| Bao, W | 3 |
| Liu, B | 4 |
| Snetselaar, LG | 3 |
| Wallace, RB | 3 |
| Shadyab, AH | 3 |
| Saquib, N | 3 |
| Cheng, TD | 3 |
| Johnson, KC | 3 |
| Hashad, RA | 3 |
| Jap, E | 3 |
| Casey, JL | 3 |
| Candace Ho, YT | 3 |
| Wright, A | 3 |
| Thalmann, C | 3 |
| Sleeman, M | 3 |
| Lupton, DW | 3 |
| Hagemeyer, CE | 3 |
| Cryle, MJ | 3 |
| Robert, R | 3 |
| Alt, K | 3 |
| El-Kenawi, A | 2 |
| Berglund, A | 2 |
| Estrella, V | 2 |
| Zhang, Y | 3 |
| Liu, M | 3 |
| Putney, RM | 2 |
| Yoder, SJ | 2 |
| Johnson, J | 2 |
| Brown, J | 2 |
| Gatenby, R | 2 |
| Guo, H | 1 |
| Xu, W | 1 |
| Nomoto, T | 1 |
| Kanamori, K | 1 |
| Voon, YM | 1 |
| Honda, Y | 1 |
| Yamada, N | 1 |
| Takemoto, H | 1 |
| Matsui, M | 1 |
| Nishiyama, N | 1 |
| Zheng, X | 1 |
| Liu, Y | 2 |
| Zhang, T | 1 |
| Zhao, Y | 1 |
| Zang, J | 1 |
| Chong, G | 1 |
| Li, Y | 2 |
| Yang, Y | 2 |
| Gu, J | 1 |
| He, R | 1 |
| Yin, W | 1 |
| Dong, H | 1 |
| Eymard, N | 1 |
| Bessonov, N | 1 |
| Volpert, V | 1 |
| Kurbatova, P | 1 |
| Gueyffier, F | 1 |
| Nony, P | 1 |
| Zhang, L | 1 |
| Liu, Z | 1 |
| Zhu, J | 1 |
| Ren, J | 1 |
| Qu, X | 1 |
| Pandit, M | 1 |
| Kil, YS | 1 |
| Ahn, JH | 1 |
| Pokhrel, RH | 1 |
| Gu, Y | 1 |
| Mishra, S | 1 |
| Han, Y | 1 |
| Ouh, YT | 1 |
| Kang, B | 1 |
| Jeong, MS | 1 |
| Kim, JO | 1 |
| Nam, JW | 1 |
| Ko, HJ | 1 |
| Chang, JH | 1 |
| Zhou, S | 1 |
| Lin, Y | 1 |
| Zhao, Z | 1 |
| Lai, Y | 1 |
| Lu, M | 1 |
| Shao, Z | 1 |
| Mo, X | 1 |
| Mu, Y | 1 |
| Liang, Z | 1 |
| Wang, X | 1 |
| Qu, J | 1 |
| Shen, H | 1 |
| Li, F | 1 |
| Zhao, AZ | 1 |
| Ishida, A | 1 |
| Kaneko, K | 1 |
| Minamimoto, R | 1 |
| Hotta, M | 1 |
| Inoshita, N | 1 |
| Takano, K | 1 |
| Yamada, S | 1 |
| Joulia, E | 1 |
| Metallo, CM | 1 |
| Ji, M | 1 |
| Xu, X | 2 |
| Xu, Q | 1 |
| Hsiao, YC | 1 |
| Martin, C | 1 |
| Ukraintseva, S | 1 |
| Popov, V | 1 |
| Arbeev, KG | 1 |
| Randall, TA | 1 |
| Wu, X | 1 |
| Garcia-Peterson, LM | 1 |
| Liu, J | 1 |
| Andrea Azcarate-Peril, M | 1 |
| Wan, Y | 1 |
| Yashin, AI | 1 |
| Anantharaman, K | 1 |
| Lu, K | 1 |
| Li, JL | 1 |
| Shats, I | 1 |
| Li, X | 1 |
| Yue, TTC | 1 |
| Ge, Y | 1 |
| Aprile, FA | 1 |
| Ma, MT | 1 |
| Pham, TT | 1 |
| Long, NJ | 1 |
| Lu, W | 1 |
| Luo, Y | 1 |
1 review available for racemethionine and Benign Neoplasms
| Article | Year |
|---|---|
Stemness of Normal and Cancer Cells: The Influence of Methionine Needs and SIRT1/PGC-1α/PPAR-α Players.
Topics: Methionine; Neoplasms; Neoplastic Stem Cells; PPAR alpha; Racemethionine; S-Adenosylmethionine; Sirt | 2022 |
Stemness of Normal and Cancer Cells: The Influence of Methionine Needs and SIRT1/PGC-1α/PPAR-α Players.
Topics: Methionine; Neoplasms; Neoplastic Stem Cells; PPAR alpha; Racemethionine; S-Adenosylmethionine; Sirt | 2022 |
Stemness of Normal and Cancer Cells: The Influence of Methionine Needs and SIRT1/PGC-1α/PPAR-α Players.
Topics: Methionine; Neoplasms; Neoplastic Stem Cells; PPAR alpha; Racemethionine; S-Adenosylmethionine; Sirt | 2022 |
Stemness of Normal and Cancer Cells: The Influence of Methionine Needs and SIRT1/PGC-1α/PPAR-α Players.
Topics: Methionine; Neoplasms; Neoplastic Stem Cells; PPAR alpha; Racemethionine; S-Adenosylmethionine; Sirt | 2022 |
Stemness of Normal and Cancer Cells: The Influence of Methionine Needs and SIRT1/PGC-1α/PPAR-α Players.
Topics: Methionine; Neoplasms; Neoplastic Stem Cells; PPAR alpha; Racemethionine; S-Adenosylmethionine; Sirt | 2022 |
Stemness of Normal and Cancer Cells: The Influence of Methionine Needs and SIRT1/PGC-1α/PPAR-α Players.
Topics: Methionine; Neoplasms; Neoplastic Stem Cells; PPAR alpha; Racemethionine; S-Adenosylmethionine; Sirt | 2022 |
Stemness of Normal and Cancer Cells: The Influence of Methionine Needs and SIRT1/PGC-1α/PPAR-α Players.
Topics: Methionine; Neoplasms; Neoplastic Stem Cells; PPAR alpha; Racemethionine; S-Adenosylmethionine; Sirt | 2022 |
Stemness of Normal and Cancer Cells: The Influence of Methionine Needs and SIRT1/PGC-1α/PPAR-α Players.
Topics: Methionine; Neoplasms; Neoplastic Stem Cells; PPAR alpha; Racemethionine; S-Adenosylmethionine; Sirt | 2022 |
Stemness of Normal and Cancer Cells: The Influence of Methionine Needs and SIRT1/PGC-1α/PPAR-α Players.
Topics: Methionine; Neoplasms; Neoplastic Stem Cells; PPAR alpha; Racemethionine; S-Adenosylmethionine; Sirt | 2022 |
15 other studies available for racemethionine and Benign Neoplasms
| Article | Year |
|---|---|
Methionine deficiency facilitates antitumour immunity by altering m
Topics: Animals; CD8-Positive T-Lymphocytes; Methionine; Methylation; Mice; Neoplasms; Programmed Cell Death | 2023 |
Changes in Dietary Intake of Methionine, Folate/Folic Acid and Vitamin B12 and Survival in Postmenopausal Women with Breast Cancer: A Prospective Cohort Study.
Topics: Animals; Eating; Female; Folic Acid; Methionine; Neoplasms; Postmenopause; Prospective Studies; Race | 2022 |
Changes in Dietary Intake of Methionine, Folate/Folic Acid and Vitamin B12 and Survival in Postmenopausal Women with Breast Cancer: A Prospective Cohort Study.
Topics: Animals; Eating; Female; Folic Acid; Methionine; Neoplasms; Postmenopause; Prospective Studies; Race | 2022 |
Changes in Dietary Intake of Methionine, Folate/Folic Acid and Vitamin B12 and Survival in Postmenopausal Women with Breast Cancer: A Prospective Cohort Study.
Topics: Animals; Eating; Female; Folic Acid; Methionine; Neoplasms; Postmenopause; Prospective Studies; Race | 2022 |
Changes in Dietary Intake of Methionine, Folate/Folic Acid and Vitamin B12 and Survival in Postmenopausal Women with Breast Cancer: A Prospective Cohort Study.
Topics: Animals; Eating; Female; Folic Acid; Methionine; Neoplasms; Postmenopause; Prospective Studies; Race | 2022 |
Changes in Dietary Intake of Methionine, Folate/Folic Acid and Vitamin B12 and Survival in Postmenopausal Women with Breast Cancer: A Prospective Cohort Study.
Topics: Animals; Eating; Female; Folic Acid; Methionine; Neoplasms; Postmenopause; Prospective Studies; Race | 2022 |
Changes in Dietary Intake of Methionine, Folate/Folic Acid and Vitamin B12 and Survival in Postmenopausal Women with Breast Cancer: A Prospective Cohort Study.
Topics: Animals; Eating; Female; Folic Acid; Methionine; Neoplasms; Postmenopause; Prospective Studies; Race | 2022 |
Changes in Dietary Intake of Methionine, Folate/Folic Acid and Vitamin B12 and Survival in Postmenopausal Women with Breast Cancer: A Prospective Cohort Study.
Topics: Animals; Eating; Female; Folic Acid; Methionine; Neoplasms; Postmenopause; Prospective Studies; Race | 2022 |
Changes in Dietary Intake of Methionine, Folate/Folic Acid and Vitamin B12 and Survival in Postmenopausal Women with Breast Cancer: A Prospective Cohort Study.
Topics: Animals; Eating; Female; Folic Acid; Methionine; Neoplasms; Postmenopause; Prospective Studies; Race | 2022 |
Changes in Dietary Intake of Methionine, Folate/Folic Acid and Vitamin B12 and Survival in Postmenopausal Women with Breast Cancer: A Prospective Cohort Study.
Topics: Animals; Eating; Female; Folic Acid; Methionine; Neoplasms; Postmenopause; Prospective Studies; Race | 2022 |
Chemoselective Methionine Labelling of Recombinant Trastuzumab Shows High In Vitro and In Vivo Tumour Targeting.
Topics: Alkynes; Animals; Antibodies, Monoclonal; Azides; Humans; Methionine; Neoplasms; Racemethionine; Tra | 2023 |
Chemoselective Methionine Labelling of Recombinant Trastuzumab Shows High In Vitro and In Vivo Tumour Targeting.
Topics: Alkynes; Animals; Antibodies, Monoclonal; Azides; Humans; Methionine; Neoplasms; Racemethionine; Tra | 2023 |
Chemoselective Methionine Labelling of Recombinant Trastuzumab Shows High In Vitro and In Vivo Tumour Targeting.
Topics: Alkynes; Animals; Antibodies, Monoclonal; Azides; Humans; Methionine; Neoplasms; Racemethionine; Tra | 2023 |
Chemoselective Methionine Labelling of Recombinant Trastuzumab Shows High In Vitro and In Vivo Tumour Targeting.
Topics: Alkynes; Animals; Antibodies, Monoclonal; Azides; Humans; Methionine; Neoplasms; Racemethionine; Tra | 2023 |
Elevated Methionine Flux Drives Pyroptosis Evasion in Persister Cancer Cells.
Topics: Apoptosis; Cell Death; Humans; Inflammasomes; Methionine; Neoplasms; Pyroptosis; Racemethionine | 2023 |
Elevated Methionine Flux Drives Pyroptosis Evasion in Persister Cancer Cells.
Topics: Apoptosis; Cell Death; Humans; Inflammasomes; Methionine; Neoplasms; Pyroptosis; Racemethionine | 2023 |
Elevated Methionine Flux Drives Pyroptosis Evasion in Persister Cancer Cells.
Topics: Apoptosis; Cell Death; Humans; Inflammasomes; Methionine; Neoplasms; Pyroptosis; Racemethionine | 2023 |
Elevated Methionine Flux Drives Pyroptosis Evasion in Persister Cancer Cells.
Topics: Apoptosis; Cell Death; Humans; Inflammasomes; Methionine; Neoplasms; Pyroptosis; Racemethionine | 2023 |
Polymeric ligands comprising sulfur-containing amino acids for targeting tumor-associated amino acid transporters.
Topics: Amino Acid Transport Systems; Amino Acids; Humans; Large Neutral Amino Acid-Transporter 1; Methionin | 2023 |
Labeling Assembly of Hydrophilic Methionine into Nanoparticle for Mild-Heat Mediated Immunometabolic Therapy.
Topics: Amino Acids; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Hot Temperature; Humans; Methionine; Nano | 2023 |
Pharmacokinetic/pharmacodynamic model of a methionine starvation based anti-cancer drug.
Topics: Animals; Antineoplastic Agents; Erythrocytes; Humans; Methionine; Mice; Neoplasms; Racemethionine | 2023 |
Selective Methionine Pool Exhaustion Mediated by a Sequential Positioned MOF Nanotransformer for Intense Cancer Immunotherapy.
Topics: Antineoplastic Agents; Humans; Immunotherapy; Metal-Organic Frameworks; Methionine; Neoplasms; Polya | 2023 |
Methionine consumption by cancer cells drives a progressive upregulation of PD-1 expression in CD4 T cells.
Topics: AMP-Activated Protein Kinases; Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Fema | 2023 |
Targeted deprivation of methionine with engineered Salmonella leads to oncolysis and suppression of metastasis in broad types of animal tumor models.
Topics: Animals; Humans; Methionine; Models, Animal; Neoplasms; Racemethionine; Salmonella typhimurium | 2023 |
Clinical decision-making based on 11C-methionine PET in recurrent Cushing's disease with equivocal MRI findings.
Topics: Carbon Radioisotopes; Clinical Decision-Making; Female; Humans; Magnetic Resonance Imaging; Male; Me | 2023 |
Methionine and H
Topics: Humans; Methionine; Neoplasms; Racemethionine | 2023 |
Methionine restriction-induced sulfur deficiency impairs antitumour immunity partially through gut microbiota.
Topics: Animals; Female; Gastrointestinal Microbiome; Hydrogen Sulfide; Male; Methionine; Mice; Neoplasms; R | 2023 |
Site-Specific
Topics: Animals; Cell Line, Tumor; Chelating Agents; Deferoxamine; Gallium Radioisotopes; Immunoconjugates; | 2023 |
Methionine restriction sensitizes cancer cells to immunotherapy.
Topics: Apoptosis; Humans; Immunotherapy; Methionine; Neoplasms; Racemethionine | 2023 |